Literature DB >> 20156250

Relationship of horse owner assessed respiratory signs index to characteristics of recurrent airway obstruction in two Warmblood families.

E Laumen1, M G Doherr, V Gerber.   

Abstract

REASONS FOR PERFORMING STUDY: The horse owner assessed respiratory signs index (HOARSI-1-4, healthy, mildly, moderately and severely affected, respectively) is based on owner-reported clinical history and has been used for the investigation of recurrent airway obstruction (RAO) genetics utilising large sample sizes. Reliable phenotype identification is of paramount importance in genetic studies. Owner reports of respiratory signs have shown good repeatability, but the agreement of HOARSI with an in-depth examination of the lower respiratory tract has not been investigated.
OBJECTIVES: To determine the correlation of HOARSI grades 3/4 with the characteristics of RAO and of HOARSI-2 with the characteristics of inflammatory airway disease. Further, to test whether there are phenotypic differences in the manifestation of lung disease between families.
METHODS: Seventy-one direct offspring of 2 RAO-affected Warmblood stallions (33 from the first family, 38 from the second) were graded as HOARSI-1-4 and underwent a clinical examination of the respiratory system, arterial blood gas analysis, endoscopic mucus scoring, cytology of tracheobronchial secretion (TBS) and bronchoalveolar lavage fluid (BALF), and clinical assessment of airway reactivity to methacholine chloride.
RESULTS: HOARSI-3/4 animals in clinical exacerbation showed signs consistent with RAO: coughing, nasal discharge, abnormal lung sounds and breathing pattern as well as increased numbers of neutrophils in TBS and BALF, excessive mucus accumulation and airway hyper-responsiveness to methacholine. HOARSI-3/4 horses in remission only had increased amounts of tracheal mucus and TBS neutrophil percentages. Clinical phenotypes were not significantly different between the 2 families. CONCLUSIONS AND CLINICAL RELEVANCE: HOARSI reliably identifies RAO-affected horses in our population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20156250     DOI: 10.2746/042516409X479586

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  15 in total

1.  Comparison of genomic and proteomic data in recurrent airway obstruction affected horses using Ingenuity Pathway Analysis®.

Authors:  Julien Racine; Vinzenz Gerber; Marybeth Miskovic Feutz; C Paige Riley; Jiri Adamec; June E Swinburne; Laurent L Couetil
Journal:  BMC Vet Res       Date:  2011-08-15       Impact factor: 2.741

2.  Impaired Cell Cycle Regulation in a Natural Equine Model of Asthma.

Authors:  Alicja Pacholewska; Vidhya Jagannathan; Michaela Drögemüller; Jolanta Klukowska-Rötzler; Simone Lanz; Eman Hamza; Emmanouil T Dermitzakis; Eliane Marti; Tosso Leeb; Vincent Gerber
Journal:  PLoS One       Date:  2015-08-20       Impact factor: 3.240

3.  Evaluation of coughing and nasal discharge as early indicators for an increased risk to develop equine recurrent airway obstruction (RAO).

Authors:  S Bosshard; V Gerber
Journal:  J Vet Intern Med       Date:  2014-01-13       Impact factor: 3.333

4.  Inflammatory Airway Disease of Horses--Revised Consensus Statement.

Authors:  L L Couëtil; J M Cardwell; V Gerber; J-P Lavoie; R Léguillette; E A Richard
Journal:  J Vet Intern Med       Date:  2016-01-24       Impact factor: 3.333

5.  Differential Expression of Serum MicroRNAs Supports CD4⁺ T Cell Differentiation into Th2/Th17 Cells in Severe Equine Asthma.

Authors:  Alicja Pacholewska; Matthias F Kraft; Vincent Gerber; Vidhya Jagannathan
Journal:  Genes (Basel)       Date:  2017-12-12       Impact factor: 4.096

6.  Insect Bite Hypersensitivity in Horses is Associated with Airway Hyperreactivity.

Authors:  S Lanz; A Brunner; C Graubner; E Marti; V Gerber
Journal:  J Vet Intern Med       Date:  2017-09-18       Impact factor: 3.333

7.  Allergen-specific immunoglobulin E in sera of horses affected with insect bite hypersensitivity, severe equine asthma or both conditions.

Authors:  Maëva Verdon; Simone Lanz; Claudio Rhyner; Vinzenz Gerber; Eliane Marti
Journal:  J Vet Intern Med       Date:  2018-12-06       Impact factor: 3.333

8.  Immunomodulatory asthma therapy in the equine animal model: A dose-response study and evaluation of a long-term effect.

Authors:  John Klier; Carolin Bartl; Sabine Geuder; Katharina J Geh; Sven Reese; Lutz S Goehring; Gerhard Winter; Heidrun Gehlen
Journal:  Immun Inflamm Dis       Date:  2019-05-29

9.  eQTL discovery and their association with severe equine asthma in European Warmblood horses.

Authors:  Victor C Mason; Robert J Schaefer; Molly E McCue; Tosso Leeb; Vinzenz Gerber
Journal:  BMC Genomics       Date:  2018-08-02       Impact factor: 3.969

Review 10.  Equine asthma: Integrative biologic relevance of a recently proposed nomenclature.

Authors:  Stephanie Bond; Renaud Léguillette; Eric A Richard; Laurent Couetil; Jean-Pierre Lavoie; James G Martin; R Scott Pirie
Journal:  J Vet Intern Med       Date:  2018-10-07       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.